selected publications
-
Genomic Methods Identify Homologous Recombination Deficiency in Pancreas Adenocarcinoma and Optimize Treatment Selection.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2020
Academic Article
GET IT
Times cited: 94 -
Reply to N. Fazio.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2020
Letter
GET IT
Times cited: 1 -
Association of the prognostic model iSEND with PD-1/L1 monotherapy outcome in non-small-cell lung cancer.
British journal of cancer.
2019
Academic Article
GET IT
Times cited: 23 -
Clinical and Immunological Implications of Frameshift Mutations in Lung Cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
2019
Academic Article
GET IT
Times cited: 24 -
Clinical Implications of Circulating Tumor DNA Tumor Mutational Burden (ctDNA TMB) in Non-Small Cell Lung Cancer.
The oncologist.
2019
Academic Article
GET IT
Times cited: 67 -
Cost-effectiveness of Osimertinib in the First-Line Treatment of Patients With EGFR-Mutated Advanced Non-Small Cell Lung Cancer.
JAMA oncology.
2018
Academic Article
GET IT
Times cited: 83 -
Autoimmune haemolytic anaemia in a patient with advanced lung adenocarcinoma and chronic lymphocytic leukaemia receiving nivolumab and intravenous immunoglobulin.
2018
GET IT
Times cited: 11 -
The Concept of Biosimilars: From Characterization to Evolution-A Narrative Review.
The oncologist.
2017
Review
GET IT
Times cited: 20 -
Developing a Predictive Model for Clinical Outcomes of Advanced Non-Small Cell Lung Cancer Patients Treated With Nivolumab.
Clinical lung cancer.
2017
Academic Article
GET IT
Times cited: 42 -
Long-term survival based on pathologic response to neoadjuvant therapy in esophageal cancer.
The Journal of surgical research.
2017
Academic Article
GET IT
Times cited: 18 -
Heat shock protein 90 promotes epithelial to mesenchymal transition, invasion, and migration in colorectal cancer.
Molecular carcinogenesis.
2014
Academic Article
GET IT
Times cited: 67 -
Antiangiogenic effects of ganetespib in colorectal cancer mediated through inhibition of HIF-1α and STAT-3.
Angiogenesis.
2013
Academic Article
GET IT
Times cited: 67 -
New perspectives of curcumin in cancer prevention.
Cancer prevention research (Philadelphia, Pa.).
2013
Review
GET IT
Times cited: 208 -
Crosstalk from survival to necrotic death coexists in DU-145 cells by curcumin treatment.
Cellular signalling.
2013
Academic Article
GET IT
Times cited: 16 -
A dual-targeting antibody against EGFR-VEGF for lung and head and neck cancer treatment.
International journal of cancer.
2011
Academic Article
GET IT
Times cited: 33